Gynecology

A recent study in Cancer Epidemiology, Biomarkers & Prevention indicates that the link between breast cancer and fertility drugs may not be as strong as previously suspected.

The reported outcomes for the da Vinci robot have been disappointing, but a new study shows that surgeons can achieve expert-level results using the Morristown Protocol.

Was there an unreasonable delay in making the diagnosis, and did that delay have an effect on the patient’s treatment and overall life expectancy?

The best strategy for identifying pelvic masses and triaging patients to the appropriate surgeons.

In this first installment of a regular series, a doctor test-drives two surgical tools and finds them friendly and functional.

New research expected this year will bring about significant changes to clinical practice. Here, society leaders share what’s on their radar for 2014.

The two widely used surgeries for apical prolapse work equally well for both apical prolapse and stress urinary incontinence two years postsurgery, research shows.

What research from the past year will have the most significant impact on women's health care? The leaders of five major ob/gyn societies weigh in.

In a unanimous vote, a Food and Drug Administration (FDA) advisory committee has recommended that the agency give premarket approval to a human papillomavirus (HPV) DNA test as first-line screening for cervical cancer.

According to a recent study in JAMA, neither the sacrospinous ligament fixation (SSLF) nor the uterosacral ligament vaginal vault suspension (ULS) procedure is superior to the other in the treatment of vaginal prolapse and stress urinary incontinence.

A head-to-head comparison of salpingotomy and salpingectomy finds that removing the affected tube after an ectopic pregnancy doesn’t affect fertility as expected.

Diet can’t cure endometriosis, but dietary recommendations could be part of the treatment. Find out here why choosing certain foods may help reduce symptoms.

A study by Canadian researchers shows that preventive oophorectomy reduces risk of ovarian, fallopian tube, or peritoneal cancer by 80% in women who have BRCA1 or BRCA2 mutations. Published in The Journal of Clinical Oncology, the report also documented a 77% reduction in all-cause mortality.

Researchers identified a distinctive profile of cytokine activity in women with endometriosis, which could lead to the development of a clinically useful patient stratification system.

Ovarian cancer is notorious for its late stage at diagnosis and its poor prognosis. In the absence of good screening tests, salpingectomy is the only form of prophylaxis for this cancer.

When a postmenopausal patient presents with signs and symptoms of a gynecologic malignancy, one should consider the possibility of genital tuberculosis in women who have immigrated to the United States.

Gynecologic surgeons should give consideration to the balance of benefit and harm that accompanies laparoscopic tissue morcellation, in addition to exploring surgical alternatives and methods to mitigate complications.

Some societies and institutions are developing formal policies on morcellation in response to an increase in public concern over the possibility of this procedure spreading and upstaging undetected cancer in the uterus.

A daily regimen of low-dose (

Premenopausal removal of the ovaries accelerates bone loss and carotid artery thickening in postmenopausal women, putting women at higher risk for both osteoporosis and cardiovascular disease.

Taking hormone replacement therapy (HRT) for at least 6 months after total knee arthroplasty (TKA) or total hip arthroplasty (THA) may reduce risk of repeat surgery. So say the results of a community-based cohort study of women in the UK who had undergone TKA or THA for osteoarthritis.

Conservative surgery for early-stage vulvar cancer had little to no long-term effect on a woman’s sexuality or body image, a small study found.

The latest devices and gadgetry for minimally invasive gynecological surgery were featured in the exhibit hall at the 42nd AAGL Global Congress on Minimally Invasive Gynecology held just outside of Washington, DC, November 10-14, 2013.